Fundraising Fox
/Companies
Sign in

Bullseye Biosciences

2 known investors

Find your way into Bullseye Biosciences

608 people in our graph share verified history with the Bullseye Biosciences team — schools, employers, funds. One of them is your warm intro.

Binsen Liunlockedknows Michael McKeown · together at Dana Farber Cancer Institute (overlapped)
×7knows the team · via Dana Farber Cancer Institute
knows the team · via Cygnal Therapeutics
knows the team · via Kronos Bio
×2knows the team · via Constellation Pharma

Bullseye Biosciences uses in-cell directed evolution to discover functional therapeutic molecules against challenging intracellular targets such as protein–protein interactions and transcriptional regulation. Its platform selects molecules like macrocyclic and stapled peptides based on their biological effect inside living cells, with applications in oncology, immunology, and other serious diseases.

BiotechDeep Tech

Founders & leadership

CGCorey Gray
Corey GrayCo-founder and CEO
MMMichael McKeown
Michael McKeownCo-founder and Head of ResearchHe serves as an advisor and scientific consultant for Longtail Healthcare Ventures.

Investors · 2

ZAKA VClisted by ZAKA VCSan Francisco

Competitors · 3

by search overlap
bio4 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Ideaya Biosciences3 shared keywordsIDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers. Its lead candidate, darovasertib, is in late-stage trials for uveal melanoma, with a pipeline spanning PKC inhibition, ADC+DDR combinations, the MTAP pathway, and KAT6/7 inhibition.
Blaze Bioscience3 shared keywordsBlaze Bioscience develops peptide-based fluorescent imaging agents and imaging systems that give surgeons real-time visualization of tumor tissue during cancer surgery. Its technology serves surgical oncology, with breast-conserving surgery and pediatric/adult brain cancer as lead indications.

Companies competing with Bullseye Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Bullseye Biosciences do?
Bullseye Biosciences uses in-cell directed evolution to discover functional therapeutic molecules against challenging intracellular targets such as protein–protein interactions and transcriptional regulation. Its platform selects molecules like macrocyclic and stapled peptides based on their biological effect inside living cells, with applications in oncology, immunology, and other serious diseases.
Who founded Bullseye Biosciences?
Bullseye Biosciences was founded by Corey Gray, Michael McKeown.
Who are Bullseye Biosciences's investors?
Bullseye Biosciences's investors include Illumina Ventures, ZAKA VC.